The HCPLive pain page is a resource for medical news and expert insights on pain medicine. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for acute pain, chronic pain, addiction medicine, and more.
October 23rd 2024
In the complete response letter, the FDA classified deficiencies in the Abbreviated New Drug Application for ketamine as MINOR.
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Hypermobility Conditions Treatment Hampered Due to Lack of Clinical Understanding
Mobility is great. Hypermobility? Less great. In the joints, hypermobility leads to musculoskeletal pain – and often times, lots of it. A recent review in the Journal of Pain Research outlined several of the challenges in treating generalized joint hypermobility (GJH) and found many difficult questions and few easy answers.
Is it Time to Revise Opioid Prescribing Guidelines (Again)?
August 21st 2015Study results show that opioid overdoses appear to frequently occur in patients who are not chronic users with high prescribed doses of opioids, in contrast to the patient groups targeted by current opioid prescribing guidelines.
Does the Analgesic Placebo Response Differ in Children?
There has been a great deal of study on the placebo effect in the medical literature, and despite some evidence suggesting that placebo response rates in randomized controlled trials are higher in children and adolescents compared to adults, there has only been limited research involving the placebo response of children.
Studies: Exercise and Sleep Are Key in Ankylosing Spondylitis
A recent study suggests that patients with ankylosing spondylitis (AS) have a higher incidence of obstructive sleep apnea syndrome that increases with the severity of cervical vertebral involvement. A separate study published on the same day suggests that specific exercise regimens may be beneficial for patients with AS.
Lack of Standardized Measurements Clouds Picture of Pain Interventions
Data concerning general outcomes and indicating performance of general pain clinics remain sparse, according to a study in the Journal of Pain and Research. The United Kingdom study suggests that this lack of standardized measurements negatively impacts the ability to judge the overall effectiveness of pain clinics, both in the UK and in other parts of the world.
Cluster Headache Remains an Enigma Despite Clinical Clues
A recent study in The Journal of Headache and Pain sheds some additional light on the chronobiological experience of patients with cluster headache (CH). However, it still leaves lingering mysteries around the pattern of pain CH that patients typically experience, the triggers of those headaches, and the mechanisms and interactions that drive headache frequency and severity.
RAPID3 Shown to Be an Effective Assessment Tool for Patients with Psoriatic Arthritis
New research suggests that a 10-second self assessment might provide nearly as much information about psoriatic arthritis case progression as complex tests that generally require either require laboratory results or formal joint-by-joint evaluation.
Chronic Low Back Pain: Pregabalin Helps Reduce Pain and Sleep Interference
A new study suggests that pregabalin shows significantly greater improvements in pain-related interference of sleep relative to usual care in patients with chronic low back pain with accompanying neuropathic pain (CLBP-NeP).
Predicting Fracture Risk in Patients with Osteoporosis
In 2014, the fracture risk algorithm FRAX celebrated its 20-year anniversary. Developed by a World Health Organization (WHO) study group in 1994, FRAX is a freely available diagnostic tool used to evaluate the 10-year probability of bone fracture risk, mostly for patients with osteoporosis. It is a part of many national health guidelines worldwide.
Plasma Exchange May Be Effective Treatment for CRPS
Complex regional pain syndrome (CRPS) is one of the pain conditions that has remained fairly mysterious, but a new, effective treatment may be on the horizon. It is known that CRPS most often develops following trauma, however, and evidence suggests a maladaptive response to nervous system damage involving immune and inflammatory pathways as well as abnormalities in both peripheral and central processing of afferent inputs. No single therapy – including pharmacologic therapy – wholly addresses the condition.
Two Extra Minutes for Medication Safety?
As the population ages and medicine continues to advance, people are living longer and healthier; but they are also taking more medications for more medical conditions. Those medications can cause drug-drug interactions that lead to adverse drug reactions (ADR). Studies have shown that the majority of medication errors happen at the stage of prescription.
Study: No Clinical Connection between Opioid Use and Breast Cancer Recurrence
Researchers who looked at the potential association between post-diagnosis opioid use and breast cancer recurrence found no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence.